Version 4.0.200811







Short description of cell lines.
Species: human


- By selecting the cell line name, you will receive the detailed description of the cell line
- By selecting one of the terms between parentheses, you will receive the list of all rilevant cell line
- You can search any term of the list by using the 'Find' utility of your Browser

1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1184 (skin, fibroblast) - ECACC
1221 (skin, fibroblast) - ECACC
1301 (blood, leukemia, acute lymphoblastic T cell) - ICLC
1306 (skin, fibroblast) - ECACC
1321N1 (brain, astrocytoma) - ECACC
142BR (skin, fibroblast) - ECACC
143 B (bone, osteosarcoma) - IZSBS
143B (bone, osteosarcoma) - ECACC
149BR (skin, fibroblast) - ECACC
153BR (skin, fibroblast) - ECACC
155BR (skin, fibroblast) - ECACC
161BR (skin, fibroblast) - ECACC
162 (skin, fibroblast) - BGEBS
163 (skin, fibroblast) - BGEBS
171BR (skin, fibroblast) - ECACC
174BR (skin, fibroblast) - ECACC
175BR (skin, fibroblast) - ECACC
180BR (skin, fibroblast) - ECACC
1BR.3.G (skin, fibroblast) - ECACC
1BR.3.GN (skin, fibroblast) - ECACC
1BR.3.N (skin, fibroblast) - ECACC
1BR3 (skin, fibroblast) - ECACC
2.2.15 (liver) - TOHEP
200D (ovary, adenocarcinoma) - ECACC
23132/87 (stomach, adenocarcinoma) - DSMZ
253D (ascitic fluid, adenocarcinoma) - ECACC
293 (kidney, embryonic) - ECACC
293 (kidney, embryonic) - ICLC
293 (kidney, embryonic) - MWIIW
293 (kidney, embryonic) - SPBIC
293 N3S (kidney, embryonic) - ECACC
293T (kidney, embryonic) - ICLC
2T (sarcoma, osteogenic) - MWIIW
380 (peripheral blood, leukemia, pre-B cell) - DSMZ
380 (peripheral blood, leukemia, pre-B cell) - ICLC
3A sub E (placenta) - ECACC
46Br.1G1 (skin, fibroblast) - ECACC
46BR.1N (skin) - ECACC
5637 (bladder, carcinoma) - DSMZ
5637 (bladder, carcinoma) - ICLC
598_81H (fibroblast) - GGB
59M (ovary, carcinoma) - ECACC
60H9(9)D10.E6 (B cell, chronic Hepatitis C) - ECACC
665/2 (skin, melanoma) - MIDOD
665/2 (skin, melanoma) - MIISB
697 (bone marrow, leukemia, pre-B cell) - DSMZ
81.3 (lymphoblast) - ECACC
8305C (thyroid, carcinoma, undifferentiated) - ECACC
8305C (thyroid, carcinoma, undifferentiated) - ICLC
84BR (skin, fibroblast) - ECACC
8505C (thyroid, carcinoma, undifferentiated) - DSMZ
8505C (thyroid, carcinoma, undifferentiated) - ECACC
9229 (lymph node, metastasis, melanoma) - MIDOD
9923 (skin, melanoma) - MIDOD

1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A 172 (nervous system, glioblastoma) - ECACC
A 172 (glioblastoma) - IZSBS
A 375 (malignant melanoma) - IZSBS
A-172 (glioblastoma) - ICLC
A-172 (glioblastoma) - PNIOS
A-204 (rhabdomyosarcoma) - DSMZ
A-204 (muscle, rhabdomyosarcoma) - ICLC
A-204 (muscle, rhabdomyosarcoma, alveolar) - MWIIW
A-204 (muscle, rhabdomyosarcoma, alveolar) - PNIOS
A-204 (muscle, rhabdomyosarcoma, alveolar) - RMUPG
A-427 (lung, carcinoma) - DSMZ
A-427 (lung, carcinoma) - IZSBS
A-427 (lung, carcinoma) - MIEOS
A-431 (carcinoma, epidermoid) - DSMZ
A-431 (skin, carcinoma, squamous cell) - MIISB
A-431 (skin, carcinoma, squamous cell) - NAUMC
A-431 (skin, carcinoma, squamous cell) - PNIOS
A-431 (skin, carcinoma, squamous cell) - SPBIC
A-498 (kidney, carcinoma) - DSMZ
A-498 (kidney, adenocarcinoma) - ICLC
A-498 (kidney, carcinoma) - IZSBS
A-498 (kidney, carcinoma) - NAUBC
A-549 (lung, carcinoma) - DSMZ
A-704 (kidney, adenocarcinoma) - ICLC
A-704 (kidney, adenocarcinoma) - IZSBS
A-704 (kidney, adenocarcinoma) - MIEOS
A-A94 (fibroblast, trisomy 21 / Down syndrome) - GGB
A-B92a (amnion) - GGB
A-B92f (fibroblast) - GGB
A-B92v (chorionic villi, chromosome mosaic) - GGB
A-C88 (amnion, trisomy 21 / Down syndrome) - GGB
A-P92 (amnion) - GGB
A-S91 (amnion, trisomy 21 / Down syndrome) - GGB
A.704 (kidney, adenocarcinoma) - ECACC
A09194 (fibroblast, chromosome aberration) - GGB
A1594 (fibroblast, chromosome aberration) - GGB
A2058 (skin, melanoma, metastatic) - ECACC
A2058 (skin, melanoma, metastatic) - ICLC
A2780 (ovary, carcinoma) - ECACC
A2780 (ovary, adenocarcinoma) - ICLC
A2780 (ovary, carcinoma) - MIISB
A2780cis (ovary, carcinoma) - ECACC
A375 (skin, malignant melanoma) - ECACC
A431 (skin, carcinoma, squamous cell) - ECACC
A549 (lung, carcinoma) - ECACC
A549 (lung, carcinoma) - GEUEM
A549 (lung, carcinoma) - ICLC
A549 (lung, carcinoma) - IZSBS
A549 (lung, carcinoma) - MIISB
A549 (lung, carcinoma) - MWIIW
A549 (lung, carcinoma) - SPBIC
A673 (nervous system, rhabdomyosarcoma) - ECACC
A84M (lymphocyte) - GGB
A84P (lymphocyte) - GGB
A94 (fibroblast, camptomelic dwarfism) - GGB
A94M (lymphocyte) - GGB
A94P (lymphocyte) - GGB
A95 (fibroblast, dwarfism thanatophoric) - GGB
AA84F (fibroblast) - GGB
AAA95M (lymphocyte) - GGB
AC84 (lymphocyte, thanatophoric dwarfism) - GGB
AC95 (lymphocyte, cri du chat syndrome) - GGB
ACHN (kidney, adenocarcinoma) - ECACC
ACHN (kidney, adenocarcinoma) - ICLC
ACHN (kidney, adenocarcinoma) - IZSBS
ACN (neuroblastoma) - ICLC
AD94IL2 (lymphocyte) - GGB
AD94LEBV (lymphocyte) - GGB
AE 1 (pleural effusion, carcinoma, small cell) - RMICS
AE 2 (pleural effusion, carcinoma, small cell) - RMICS
AE 3 (pleural effusion, carcinoma, small cell) - RMICS
AE84S (fibroblast) - GGB
AFA95M (lymphocyte) - GGB
AG 5025 (skin, fibroblast) - BGEBS
AG95P (lymphocyte) - GGB
AGLCL (lymphocyte, B) - ECACC
AGS (stomach, adenocarcinoma) - ECACC
AGS (stomach, adenocarcinoma) - IZSBS
AJ95 (lymphocyte, corpus callosum agenesis) - GGB
ALL-PO (bone marrow, leukemia, acute lymphoblastic) - ICLC
ALM86M (lymphocyte) - GGB
AM85 (lymphocyte) - GGB
AM86 (lymphocyte) - GGB
AM95 (lymphocyte, trisomy 21 / Down syndrome) - GGB
Amdur II (skin, fibroblast, methylmalonicacidemia) - ECACC
Amdur II (skin, fibroblast, methylmalonicacidemia) - IZSBS
AML 193 (leukemia, acute myeloid) - RMSEO
AN86P (lymphocyte) - GGB
AP95 (lymphocyte, trisomy 21 / Down syndrome) - GGB
AR84S (lymphocyte) - GGB
AR91 (fibroblast, Fanconi anemia) - GGB
ARH 77 (peripheral blood, leukemia, plasma cell) - ECACC
AsPC-1 (pancreas, adenocarcinoma) - SPBIC
AT95 (lymphocyte, malformations) - GGB
AV 3 (amnion) - IZSBS
AV3 (amnion) - ECACC

1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

B-A95 (amnion) - GGB
B-B87 (amnion) - GGB
B-B88a (amnion, trisomy 21 / Down syndrome) - GGB
B-B88f (fibroblast, trisomy 21 / Down syndrome) - GGB
B-B92c (umbilical cord) - GGB
B-B92s (skin) - GGB
B-C86 (amnion, trisomy 21 / Down syndrome) - GGB
B-C89 (amnion) - GGB
B-D93 (amnion, Down syndrome, mosaic) - GGB
B-DP85 (amnion, trisomy 21 / Down syndrome) - GGB
B-F91 (amnion, Patau syndrome / trisomy 13) - GGB
B-G92 (amnion, Turner syndrome, mosaic) - GGB
B-K88 (amnion, trisomy 21 / Down syndrome) - GGB
B-L94 (amnion) - GGB
B-M 92a (amnion, trisomy 21 / Down syndrome) - GGB
B-M 92f (fibroblast, trisomy 21 / Down syndrome) - GGB
B-M91a (amnion, trisomy 21 / Down syndrome) - GGB
B-M91f (fibroblast, trisomy 21 / Down syndrome) - GGB
B-M93 (amnion) - GGB
B-P91 (amnion, Edwards' syndrome / trisomy 18) - GGB
B-P94 (amnion, trisomy 21 / Down syndrome) - GGB
B-R92 (amnion, chromosome aberration) - GGB
B-R93a (amnion, trisomy 21 / Down syndrome) - GGB
B-R93f (fibroblast, trisomy 21 / Down syndrome) - GGB
B-S95 (amnion, trisomy 21 / Down syndrome) - GGB
B-V92 (amnion) - GGB
B-Z94 (amnion, trisomy 21 / Down syndrome) - GGB
B1647 (bone marrow, leukemia) - ICLC
B192 (fibroblast, dyskeratosis) - GGB
B2195 (fibroblast, gastroschisis) - GGB
B84 (fibroblast) - GGB
B85 (fibroblast) - GGB
B86M (lymphocyte) - GGB
BA 93 (lymphocyte) - GGB
BA193 (lymphocyte) - GGB
BA96 (lymphocyte, trisomy 21 / Down syndrome) - GGB
BB96P (lymphocyte) - GGB
BC87IL2 (lymphocyte) - GGB
BC87ls (lymphocyte) - GGB
BC96 (fibroblast) - GGB
BE(2)-C (bone marrow, neuroblastoma) - ECACC
BE(2)-M17 (neural, neuroblastoma) - ECACC
BEN (lung, carcinoma) - DSMZ
BeWo (placenta, choriocarcinoma) - ECACC
BeWo (placenta, choriocarcinoma) - IZSBS
BF93 (lymphocyte) - GGB
BF95 (lymphocyte) - GGB
BF96 (lymphocyte) - GGB
BG194 (lymphocyte) - GGB
BGC-823 (stomach, adenocarcinoma, undifferentiated) - ICLC
BGF96M (lymphocyte) - GGB
BGP94 (lymphocyte) - GGB
BI96 (lymphocyte, tuberous sclerosis) - GGB
BL-41 (lymphoma, Burkitt) - DSMZ
BL-70 (lymphoma, Burkitt) - DSMZ
BL95 (lymphocyte, trisomy 21 / Down syndrome) - GGB
BLE96 (lymphocyte, tuberous sclerosis) - GGB
BLN96M (lymphocyte) - GGB
BM87 (lymphocyte) - GGB
BM95 (lymphocyte, trisomy 21 / Down syndrome) - GGB
BONNA-12 (spleen, leukemia, hairy cell) - DSMZ
BP86 (lymphocyte, chromosome aberration) - GGB
BP96 (lymphocyte, tuberous sclerosis) - GGB
BR96P (lymphocyte) - GGB
BRISTOL 8 (blood) - ECACC
BT-20 (breast, carcinoma) - GEIAP
BT-20 (breast, carcinoma) - SPBIC
BT-20 (breast, carcinoma) - TOUCI
BT-474 (breast, carcinoma, ductal) - DSMZ
BT-474 (breast, carcinoma, ductal) - ICLC
BT-474 (breast, carcinoma, ductal) - SPBIC
BT-549 (breast, carcinoma, ductal) - ICLC
BT-B (cervix, carcinoma) - DSMZ
Bu25 TK- (cervix, carcinoma, cervical) - ECACC
BUD-8 (skin, fibroblast) - ECACC
BUD-8 (skin, fibroblast) - IZSBS
BV-173 (peripheral blood, leukemia, pre-B cell) - DSMZ
BV-173 (peripheral blood, leukemia, pre-B cell) - ICLC
BxPC-3 (pancreas, adenocarcinoma) - ECACC
BXPC-3 (pancreas, adenocarcinoma) - IZSBS
BxPC3 (pancreas, adenocarcinoma) - ICLC

1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C-4 II (cervix, carcinoma, cervical) - ECACC
C-433 (bone, sarcoma, Ewing's) - DSMZ
C-4I (cervix, carcinoma, cervical) - ECACC
C-B94 (amnion, Edwards' syndrome / trisomy 18) - GGB
C-B95 (fibroblast, trisomy 21 / Down syndrome) - GGB
C-C87a (amnion, Edwards' syndrome / trisomy 18) - GGB
C-C87f (fibroblast, Edwards' syndrome / trisomy 18) - GGB
C-C90 (amnion, trisomy 21 / Down syndrome) - GGB
C-C91 (amnion, Klinefelter syndrome) - GGB
C-C95 (amnion, cri du chat syndrome) - GGB
C-D92 (amnion) - GGB
C-E 92 (amnion, trisomy 21 / Down syndrome) - GGB
C-F89 (fibroblast, trisomy 21 / Down syndrome) - GGB
C-G86 (amnion, trisomy 21 / Down syndrome) - GGB
C-M87 (fibroblast) - GGB
C-M92 (fibroblast, trisomy 21 / Down syndrome) - GGB
C-N90 (amnion, trisomy 21 / Down syndrome) - GGB
C-N95 (fibroblast, trisomy 21 / Down syndrome) - GGB
C-S91a (amnion, trisomy 21 / Down syndrome) - GGB
C-S95 (amnion, chromosome aberration) - GGB
C0092 (amnion, D. Becker syndrome) - GGB
C0994IL2 (lymphocyte, chromosome aberration) - GGB
C1191f (fibroblast, trisomy 14) - GGB
C1191v (fibroblast, trisomy 14) - GGB
C1192 (fibroblast, trisomy 7) - GGB
C1195 (fibroblast, Edwards' syndrome / trisomy 18) - GGB
C1293 (fibroblast, trisomy 21 / Down syndrome) - GGB
C1294a (amnion) - GGB
C1294f (fibroblast) - GGB
C1595a (amnion) - GGB
C1595f (fibroblast) - GGB
C16 (lung, embryonic) - ECACC
C1PV (skin, fibroblast) - PVCGU
C211 (skin, cri du chat syndrome) - ECACC
C2PV (skin, fibroblast) - PVCGU
C32 (skin, melanoma, amelanotic) - ECACC
C32 (melanoma, amelanotic) - IZSBS
C33A (cervix, carcinoma) - ICLC
C3PV (skin, fibroblast) - PVCGU
C4PV (skin, fibroblast) - PVCGU
C5MJ (lymphocyte) - RMUFM
C5PV (skin, fibroblast) - PVCGU
C6PV (skin, fibroblast, porokeratosis of Mibelli) - PVCGU
C7PV (skin, fibroblast, photosensitivity) - PVCGU
C8166 (blood, leukemia, T cell) - ECACC
C83 (fibroblast) - GGB
C86M (lymphocyte) - GGB
C86P (lymphocyte) - GGB
C87 (fibroblast) - GGB
C8PV (skin, fibroblast) - PVCGU
C91 (fibroblast, chromosome mosaic) - GGB
C91PL (lymphocyte) - RMUFM
C92 (fibroblast, D. Becker syndrome) - GGB
C93 (fibroblast, Pallister Killian syndrome) - GGB
C96 (amnion, trisomy 21 / Down syndrome) - GGB
C9PV (skin, fibroblast) - PVCGU
Ca Ski (cervix, carcinoma, epidermoid) - ECACC
Ca Ski (cervix, carcinoma) - MIISA
Ca Ski (cervix, carcinoma) - MIISB
CA-46 (lymphoma, Burkitt) - DSMZ
CA295 (lymphocyte) - GGB
CA46 (ascitic fluid, lymphoma, Burkitt) - ECACC
CA46 (ascitic fluid, lymphoma, Burkitt) - ICLC
CA95 (lymphocyte, trisomy 21 / Down syndrome) - GGB
CA96 (lymphocyte, familial epylepsy) - GGB
CACO-2 (colon, adenocarcinoma) - DSMZ
CACO-2 (colon, adenocarcinoma) - ECACC
Caco-2 (colon, adenocarcinoma) - ICLC
Caco-2 (colon, adenocarcinoma) - IZSBS
Caco-2 (colon, adenocarcinoma) - MIECC
Caco-2 (colon, adenocarcinoma) - MIUFC
Caco-2 (colon, adenocarcinoma) - RMSTC
Caco-2 (colon, adenocarcinoma) - SPBIC
CAKI 2 (kidney, carcinoma) - ECACC
CAKI-1 (kidney, carcinoma) - DSMZ
Caki-1 (kidney, carcinoma) - IZSBS
CAKI-2 (kidney, carcinoma) - DSMZ
Caki-2 (kidney, carcinoma) - ICLC
Caki-2 (kidney, carcinoma) - IZSBS
CAL-39 (vulva, carcinoma, squamous cell) - DSMZ
CALU 1 (lung, carcinoma, epidermoid) - ECACC
Calu-1 (lung, carcinoma, epidermoid, grade III) - ICLC
CaLu-1 (lung, carcinoma, epidermoid) - IZSBS
Calu-3 (lung, adenocarcinoma) - GEUEM
Calu-3 (lung, adenocarcinoma) - IZSBS
Calu-3 (lung, adenocarcinoma) - MIISB
Calu-6 (lung, adenocarcinoma) - GEUEM
Calu-6 (lung, carcinoma, anaplastic) - ICLC
CAPAN 1 (pancreas, adenocarcinoma) - IZSBS
CAPAN 2 (pancreas, carcinoma) - IZSBS
CAPAN-1 (pancreas, adenocarcinoma) - DSMZ
CAPAN-2 (pancreas, adenocarcinoma) - DSMZ
Capan-2 (pancreas, adenocarcinoma) - SPBIC
CAS-1 (glioblastoma) - ICLC
CaSki (cervix, carcinoma, epidermoid, from metastatic site) - ICLC
CC96 (lymphocyte, neurofibromatosis type I) - GGB
CCD 13Lu (lung) - ECACC
CCD 16Lu (lung) - ECACC
CCD 18Lu (lung) - ECACC
CCD 19Lu (lung) - ECACC
CCD 25Lu (lung) - ECACC
CCD 8Lu (lung) - ECACC
CCD-11Lu (lung) - ECACC
CCD-29Lu (lung) - ECACC
CCD-32Lu (lung) - ECACC
CCD-33Lu (lung) - ECACC
CCD-34Lu (lung) - ECACC
CCD-37Lu (lung) - ECACC
CCD-39Lu (lung) - ECACC
CCF-STTG1 (brain, astrocytoma) - ECACC
CCF-STTG1 (astrocytoma, anaplastic, grade IV) - IZSBS
CCM89M (lymphocyte) - GGB
CCRF-CEM (peripheral blood, leukemia, acute lymphoblastic) - ECACC
CCRF-CEM (peripheral blood, leukemia, acute lymphoblastic) - IZSBS
CCRF-CEM (peripheral blood, leukemia, acute lymphoblastic) - PSHTM
CCRF-HSB-2 (peripheral blood, leukemia, acute lymphoblastic T cell) - ECACC
CCRF-SB (peripheral blood, leukemia, acute lymphoblastic) - ECACC
CCRF-SB (peripheral blood, leukemia, acute lymphoblastic) - IZSBS
CCRF-SB (peripheral blood, leukemia, acute lymphoblastic) - SPBIC
CD86 (lymphocyte) - GGB
CD88f (fibroblast, Down syndrome, mosaic) - GGB
CD88ls (lymphocyte, Down syndrome, mosaic) - GGB
CD89P (fibroblast) - GGB
CDM96 (lymphocyte, familial epylepsy) - GGB
CEM-CM3 (leukemia, acute lymphoblastic) - GEIIB
CEM/C2 (leukemia, T cell) - IZSBS
CESS (lymphoblast, leukemia, myelomonocytic) - ECACC
CF84f (fibroblast, Down syndrome, mosaic) - GGB
CF84ls (lymphocyte, Down syndrome, mosaic) - GGB
CF89P (lymphocyte) - GGB
CF96F (lymphocyte) - GGB
CF96P (lymphocyte) - GGB
CFPAC-1 (pancreas, adenocarcinoma) - ECACC
CFPAC-1 (pancreas, adenocarcinoma, ductal) - ICLC
CG89 (lymphocyte, chromosome aberration) - GGB
CG94IL2 (lymphocyte, chromosome aberration) - GGB
CG96 (lymphocyte, neurofibromatosis type I) - GGB
Chang Liver (liver) - ECACC
Chang liver (liver) - IZSBS
Chang liver (liver) - MIISB
Chang liver (liver) - MWIIW
CHP 212 (neuroblastoma) - BOHIC
CHP 3 (skin, fibroblast, galactosemia) - IZSBS
CHP 3 (M.W.) (skin, galactosemia) - ECACC
CHP 4 (skin, fibroblast, asymptomatic galactosemia) - IZSBS
CHP 4 (W.W.) (skin, galactosemia) - ECACC
CHP-126 (neuroblastoma) - RMUPG
Citrullinemia (skin, citrullinemia) - ECACC
CL95 (lymphocyte, trisomy 21 / Down syndrome) - GGB
CL96f (fibroblast, erythroblastopenia, transient) - GGB
CL96IL2 (lymphocyte, familial epylepsy) - GGB
CLM96M (lymphocyte) - GGB
Clone 1-5c-4 (conjunctiva) - ECACC
Clone 1-5c-4 WKD of Chang Conjunctiva (conjunctiva) - IZSBS
Clone 1-5c-4 WKD of Chang Conjunctiva (conjunctiva) - MWIIW
Clone 15 HL-60 (leukemia, promyelocytic) - ECACC
CM-S/Tum (bone marrow) - ICLC
CM-S/un (bone marrow, monocyte tumor) - ICLC
CM86 (lymphocyte, trisomy 21 / Down syndrome) - GGB
CM87 (lymphocyte, trisomy 21 / Down syndrome) - GGB
CM87IL2 (lymphocyte, trisomy 21 / Down syndrome) - GGB
CM88M (lymphocyte) - GGB
CM91IL2 (lymphocyte, chromosome aberration) - GGB
CM91ls (lymphocyte, Turner syndrome/noonan syndrome 1) - GGB
CM94 (lymphocyte) - GGB
CM94P (lymphocyte) - GGB
CML-T1 (peripheral blood, leukemia, T cell) - DSMZ
CMR94M (lymphocyte) - GGB
CN96 (lymphocyte) - GGB
COLO 201 (colon, adenocarcinoma) - ECACC
COLO 205 (colon, adenocarcinoma) - ECACC
COLO 205 (colon, colorectal adenocarcinoma) - ICLC
COLO 320 DMF (colon, adenocarcinoma) - ECACC
COLO 320DM (colon, adenocarcinoma) - ECACC
COLO 320DMF (colon, adenocarcinoma) - ICLC
COLO 320HSR (colon, adenocarcinoma) - ECACC
COLO 320HSR (colon, adenocarcinoma) - SPBIC
COLO 357 (lymph node, metastasis, adenocarcinoma, pancreas) - ECACC
COLO 668 (lung, carcinoma, oat cell) - ECACC
COLO 677 (lung, carcinoma) - ECACC
COLO 679 (skin, melanoma) - ECACC
COLO 684 (uterus, adenocarcinoma) - ECACC
COLO 685 (uterus, adenocarcinoma) - ECACC
COLO 699 N (lymph node, lung cancer) - ECACC
COLO 699N (lung, adenocarcinoma) - ICLC
COLO 720 E (ascitic fluid, adenocarcinoma, ovary) - ECACC
COLO 720 L (lymphocyte, B, adenocarcinoma, ovary) - ECACC
COLO 741 (pelvic wall, metastasis, carcinoma, colon) - ECACC
COLO 741 (colon, carcinoma) - ICLC
COLO 775 (blood, leukemia) - ECACC
COLO 792 (brain, malignant melanoma) - ECACC
COLO 800 (subcutaneous nodule, melanoma) - ECACC
COLO 800 (subcutaneous nodule, melanoma) - ICLC
COLO 818 (skin, melanoma) - ECACC
COLO 829 (umbilical metastatis, melanoma) - ECACC
COLO 832 (lymph node, metastasis, melanoma) - ECACC
COLO 839 (lymphocyte, B, melanoma) - ECACC
COLO 853 (axilla lymph node, melanoma) - ECACC
COLO 853 (lymph node, melanoma) - ICLC
COLO 857 (axilla lymph node, melanoma) - ECACC
COLO 858 (right axial lymph node, melanoma) - ECACC
COLO 858 (lymph node, melanoma) - ICLC
COLO-206F (colon, carcinoma) - DSMZ
COLO-320 (colon, adenocarcinoma) - DSMZ
COLO-677 (lung, carcinoma, small cell) - DSMZ
COLO-678 (colon, carcinoma) - DSMZ
COLO-679 (melanoma) - DSMZ
COLO-680N (oesophagus, carcinoma, squamous cell) - DSMZ
COLO-699 (lung, adenocarcinoma) - DSMZ
COLO-704 (ovary, adenocarcinoma) - DSMZ
COLO-720L (lymphoblastoid B cell, adenocarcinoma) - DSMZ
COLO-800 (melanoma) - DSMZ
COLO-818 (melanoma) - DSMZ
COLO-824 (breast, carcinoma) - DSMZ
COLO-849 (melanoma, metastatic) - DSMZ
Cor Per (skin, fibroblast, Ehlers-Danlos syndrome, type IV, autosomal dominant) - BGEBS
COR-L105 (lung, adenocarcinoma) - ECACC
COR-L23 (lung, carcinoma, large cell) - ECACC
COR-L23 (lung, carcinoma, large cell) - ICLC
COR-L24 (lymph node, carcinoma, small cell) - ECACC
COR-L279 (lymph node, carcinoma, small cell) - ECACC
COR-L311 (lung, carcinoma, small cell) - ECACC
COR-L47 (bone marrow, carcinoma, lung small cell) - ECACC
COR-L51 (lung, carcinoma, lung small cell) - ECACC
COR-L88 (pleural effusion, carcinoma, lung small cell) - ECACC
CR83 (fibroblast, epidermolysis bullo'sa) - GGB
CR86 (lymphocyte, trisomy 21 / Down syndrome) - GGB
CR88P (lymphocyte) - GGB
CR96 (lymphocyte, epilepsy) - GGB
Cri du Chat (skin, fibroblast, cri du chat syndrome) - ECACC
CRO-AP2 (lymphoma, B cell) - DSMZ
CRO-AP5 (lymphoma, B cell) - DSMZ
CS191 (fibroblast, Turner syndrome, mosaic) - GGB
CS1PV (skin, fibroblast, Cockayne syndrome) - PVCGU
CS87 (lymphocyte, T, trisomy 21 / Down syndrome) - GGB
CS96 (fibroblast, Freeman-Sheldon syndrome) - GGB
CT96 (lymphocyte, hypercholesterolemia, familial) - GGB
CTV-1 (peripheral blood, leukemia, acute myeloid) - DSMZ
CV96F (lymphocyte) - GGB
CVD89M (lymphocyte) - GGB
CX-1 (colon, adenocarcinoma) - DSMZ



For information, get in touch with:

Istituto Nazionale per la Ricerca sul Cancro,
c/o Centro Biotecnologie Avanzate, Torre B - Piano 2
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy Tel: +39-0105558-289, Fax: +39-0105558-293
Email: assunta.manniello@istge.it